Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Goyal

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
Clinical Case Reports|August 28, 2018
Florid dermatopathic lymphadenopathy-A morphological mimic of Langerhans cell histiocytosisAishwarya Ravindran, Gaurav Goyal, Jarrett J Failing, et al.
JCO Clinical Cancer Informatics|May 22, 2019
Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time to First Treatment in Chronic Lymphocytic LeukemiaDavid Chen, Gaurav Goyal, Ronald S Go, et al.
British Journal of Haematology|July 6, 2018
A population-based analysis of second primary malignancies in T-cell neoplasmsAnuhya Kommalapati, Sri Harsha Tella, Ronald S Go, et al.
Translational Cancer Research|August 17, 2023
B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three casesAnna Wang, Wei Guo, Daniela Damiani, et al.
Scientific Reports|August 11, 2019
Inter-axonal recognition organizes Drosophila olfactory map formationGaurav Goyal, Ariane Zierau, Marc Lattemann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 24, 2022
Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS MutationBoyu Hu, Jay L Patel, Randa Tao, et al.
Nature Communications|February 20, 2019
Sphingolipid-dependent Dscam sorting regulates axon segregationGaurav Goyal, Junfeng Zheng, Elisabeth Adam, et al.
Ophthalmology|July 13, 2014
Author reply: To PMID 23953101Ritu Arora, Aditi Manudhane, Ravindra K Saran, et al.
JAAD Case Reports|September 11, 2025
Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinibVyshnavi Rallapalle, Lauren Kole, Peter Pavlidakey, et al.
Leukemia Research|December 17, 2021
Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approvalJohn W Thomas, Omer Jamy, Mithun Vinod Shah, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Clinical Case Reports|August 28, 2018
Florid dermatopathic lymphadenopathy-A morphological mimic of Langerhans cell histiocytosisAishwarya Ravindran, Gaurav Goyal, Jarrett J Failing, et al.
JCO Clinical Cancer Informatics|May 22, 2019
Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time to First Treatment in Chronic Lymphocytic LeukemiaDavid Chen, Gaurav Goyal, Ronald S Go, et al.
British Journal of Haematology|July 6, 2018
A population-based analysis of second primary malignancies in T-cell neoplasmsAnuhya Kommalapati, Sri Harsha Tella, Ronald S Go, et al.
Translational Cancer Research|August 17, 2023
B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three casesAnna Wang, Wei Guo, Daniela Damiani, et al.
Scientific Reports|August 11, 2019
Inter-axonal recognition organizes Drosophila olfactory map formationGaurav Goyal, Ariane Zierau, Marc Lattemann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 24, 2022
Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS MutationBoyu Hu, Jay L Patel, Randa Tao, et al.
Nature Communications|February 20, 2019
Sphingolipid-dependent Dscam sorting regulates axon segregationGaurav Goyal, Junfeng Zheng, Elisabeth Adam, et al.
Ophthalmology|July 13, 2014
Author reply: To PMID 23953101Ritu Arora, Aditi Manudhane, Ravindra K Saran, et al.
JAAD Case Reports|September 11, 2025
Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinibVyshnavi Rallapalle, Lauren Kole, Peter Pavlidakey, et al.
Leukemia Research|December 17, 2021
Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approvalJohn W Thomas, Omer Jamy, Mithun Vinod Shah, et al.
Pageof 19